生物
转录组
转录因子
表观遗传学
染色质
表观遗传学
癌症研究
表观基因组
平滑肌肉瘤
基因表达谱
恶性肿瘤
DNA甲基化
细胞
计算生物学
表型
细胞培养
抄写(语言学)
基因表达调控
病理
生物信息学
细胞生物学
后生
CpG站点
遗传学
短尾鱼
作者
Ryan A. Denu,Zhao Zheng,Yingda Jiang,Suresh Satpati,Veena Kochat,Kumaren Anand,Danh D. Truong,Andrew R. Lynch,William I. Padron,Davis R Ingram,Khalida Wani,Diana Shamsutdinova,Angela D. Bhalla,Sharon M. Landers,Ravin Ratan,Neeta Somaiah,Christina Lynn Roland,Keila E. Torres,Peter Van Loo,Pamela T. Soliman
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2026-05-26
被引量:1
标识
DOI:10.64898/2026.05.22.726988
摘要
ABSTRACT Leiomyosarcoma is a smooth muscle–derived malignancy marked by significant clinical heterogeneity. The extent and nature of cellular heterogeneity and molecular underpinnings remain poorly understood. To address this at transcriptomic and epigenomic levels, we performed single-nucleus multiome sequencing on untreated primary leiomyosarcoma tissues. Malignant cells segregated almost exclusively into two previously unrecognized and epigenetically distinct states: a dedifferentiated, mesenchymal-like subtype (MES) and a differentiated smooth muscle–enriched subtype (SMC). Chromatin accessibility profiling revealed strong enrichment of nuclear factor I (NFI) transcription factor motifs in MES cells, whereas AP-1 family motifs—most prominently FOSL2—were selectively accessible in SMC cells. Established leiomyosarcoma cell lines faithfully recapitulated these subtypes, and targeted depletion of NFI or AP-1 factors suppressed proliferation, invasion, and in vivo tumor growth, demonstrating functional dependency on these transcriptional programs. Spatial transcriptomics across 328 tissue cores from 128 leiomyosarcomas showed that immunosuppressive macrophages preferentially cluster around MES regions, revealing a subtype-specific tumor–immune niche. Clinically, MES-dominant tumors were associated with significantly worse patient outcomes. Through an epigenetic inhibitor screen, we identify and validate SMARCA4/2 inhibition as a promising therapeutic vulnerability for MES leiomyosarcomas. Together, this work defines two epigenetically driven, transcription factor–regulated, and clinically relevant states of leiomyosarcoma, revealing mechanistic underpinnings of tumor heterogeneity and uncovering actionable therapeutic strategies. GRAPHICAL ABSTRACT
科研通智能强力驱动
Strongly Powered by AbleSci AI